Agios Pharmaceuticals Logo

Agios Pharmaceuticals

🇺🇸
AGIO
US00847X1046

Agios Pharmaceuticals is a leading US biotechnology company dedicated to developing innovative therapies for rare diseases. The company focuses on researching cellular metabolism to deliver transformative medicines for individuals living with genetic blood disorders.

Next Quarterly Earnings

Thursday, October 29, 2026
CW 44
Pre-Market
In 63 days

Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).

Quiet period starts on October 1, 2026

Stock Price

Frequently asked questions

When will Agios Pharmaceuticals report its next quarterly earnings?

Agios Pharmaceuticals is scheduled to report its next quarterly earnings on 10/29/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).

When did Agios Pharmaceuticals last report quarterly earnings?

Agios Pharmaceuticals last reported quarterly earnings on 7/30/2026 (Q2 2026). Earnings per share (EPS) came in at -1.69 USD.

How often has Agios Pharmaceuticals beaten expectations?

Agios Pharmaceuticals has beaten analyst EPS estimates in 3 of its last 5 evaluated quarters (beat rate: 60%).

How do I add the Agios Pharmaceuticals earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:-$1.28
Actual:
Q2 2026
Missed
Estimate:-$1.65
Actual:-$1.69
Difference:-$0.04
Price reaction (1 day):-6.5 %
Price reaction (7 days):-8.7 %
Q1 2026
Beat
Estimate:-$1.80
Actual:-$1.69
Difference:+$0.11
Price reaction (1 day):+13.1 %
Price reaction (7 days):+8.8 %
Q3 2025
Beat
Estimate:-$1.95
Actual:-$1.85
Difference:+$0.09
Q2 2025
Beat
Estimate:-$1.90
Actual:-$1.78
Difference:+$0.12
Q1 2025
Missed
Estimate:-$1.75
Actual:-$1.93
Difference:-$0.18

Earnings statistics

Estimates vs. results

3/5
Quarters above estimates
60%
Beat rate
+0.8%
Avg. EPS surprise

Basis: 5 quarters with an analyst estimate and reported EPS.

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
Agios Pharmaceuticals
Ticker Symbol
AGIO
ISIN
US00847X1046
Country
🇺🇸
USA
Sector